
Predicta Biosciences
Developer of an oncology technology platform designed for cancer diagnosis and treatment. The company's platform specializes in integrating multi-omics and liquid biopsy technologies with non-invasive...
Valuation
$49M
Latest known
Share Price
N/A
Total Raised
$29.2M
Last Round
N/A